120 related articles for article (PubMed ID: 7942701)
21. Site of mistletoe injection observed on In-111 OncoScint imaging.
Choe W
Clin Nucl Med; 1997 Feb; 22(2):127. PubMed ID: 9031776
[No Abstract] [Full Text] [Related]
22. Planar, SPET and three-dimensional immunoscintigraphy of suspected recurrent colorectal cancer using 111In-B72.3 (Oncoscint CR-OV): effect of administered activity.
Perkins AC; Vincent RM; Wastie ML; Denton GW; Amar S; Hardcastle JD
Nucl Med Commun; 1994 Dec; 15(12):981-90. PubMed ID: 7715898
[TBL] [Abstract][Full Text] [Related]
23. Uptake of In-111 GYK-DTPA B72.3 monoclonal antibody in metastatic squamous cell carcinoma.
Blend MJ; De La Coates-Johnson R
Clin Nucl Med; 1994 Oct; 19(10):912-3. PubMed ID: 7805331
[No Abstract] [Full Text] [Related]
24. Indium-111 satumomab pendetide: the first FDA-approved monoclonal antibody for tumor imaging.
Bohdiewicz PJ
J Nucl Med Technol; 1998 Sep; 26(3):155-63; quiz 170-1. PubMed ID: 9755434
[TBL] [Abstract][Full Text] [Related]
25. Quantitative analysis of In-111 satumomab pendetide immunoscintigraphy. An aid to visual interpretation of images in patients with suspected carcinomatosis.
Neal CE; Johnson DL; Cornwell VL; Markwell S
Clin Nucl Med; 1996 Aug; 21(8):638-42. PubMed ID: 8853918
[TBL] [Abstract][Full Text] [Related]
26. Radiation absorbed dose estimates for indium-111-labeled B72.3, an IgG antibody to ovarian and colorectal cancer: MIRD dose estimate report No. 18.
Mardirossian G; Brill AB; Harwood SJ; Olsen J; Dwyer KA; Siegel JA
J Nucl Med; 1998 Apr; 39(4):671-6. PubMed ID: 9544680
[No Abstract] [Full Text] [Related]
27. In-111 CYT-103 immunoscintigraphy in the imaging of ovarian carcinoma.
Neal CE; Baker MR; Hilgers RD; Fanning J; Burke RC; Snodgrass J; Cull RD
Clin Nucl Med; 1993 Jun; 18(6):472-6. PubMed ID: 8319398
[TBL] [Abstract][Full Text] [Related]
28. Immunoscintigraphy of colorectal cancer using a monoclonal antibody 77-1.
Yiu CY; Baker LA; Davidson BR; McCready VR; Boulos PB
Eur J Surg Oncol; 1991 Oct; 17(5):495-501. PubMed ID: 1936297
[TBL] [Abstract][Full Text] [Related]
29. Immunoscintigraphy of colorectal carcinoma utilizing 111In-labeled monoclonal antibody conjugate CYT-103.
Neal CE; Swan TL; Baker MR; Ellis RL; Katterhagen JG
Gastrointest Radiol; 1991; 16(3):251-5. PubMed ID: 1879645
[TBL] [Abstract][Full Text] [Related]
30. False-positive imaging of In-111 labeled monoclonal antibody conjugate CYT-103 in a patient with metastatic colorectal carcinoma.
Bhatia M; Baron PL; Alderman DF; Gordon L
Clin Nucl Med; 1995 Nov; 20(11):979-80. PubMed ID: 8565379
[TBL] [Abstract][Full Text] [Related]
31. Intense uptake of In-111 satumomab pendetide in an inflammatory mass.
Silberstein EB; Saeks E
Clin Nucl Med; 1996 Jan; 21(1):53-5. PubMed ID: 8741891
[TBL] [Abstract][Full Text] [Related]
32. In-111 CYT-103 immunoscintigraphy of isolated splenic metastasis from ovarian carcinoma.
Nguyen BD; Regan F
Clin Nucl Med; 1997 Apr; 22(4):256-7. PubMed ID: 9099487
[No Abstract] [Full Text] [Related]
33. Diagnostic use of radiolabeled antibodies for cancer.
Harrison KA; Tempero MA
Oncology (Williston Park); 1995 Jul; 9(7):625-31 DISC 634, 636, 641. PubMed ID: 8924373
[TBL] [Abstract][Full Text] [Related]
34. Monoclonal antibody imaging of colorectal and ovarian cancer.
Haseman MK
West J Med; 1994 Oct; 161(4):412. PubMed ID: 7817555
[No Abstract] [Full Text] [Related]
35. Immunoscintigraphy using 111InCyt103 prior to second look laparotomy in ovarian cancer. A pilot study.
Hempling RE; Piver MS; Baker TR; Bakshi S; Gilani SS
Am J Clin Oncol; 1994 Aug; 17(4):331-4. PubMed ID: 8048395
[TBL] [Abstract][Full Text] [Related]
36. Clinical applications of indium-111-labeled monoclonal antibody imaging in colorectal cancer patients.
Abdel-Nabi H; Doerr RJ
Semin Nucl Med; 1993 Apr; 23(2):99-113. PubMed ID: 8511606
[TBL] [Abstract][Full Text] [Related]
37. 111In-CYT-103 immunoscintigraphy in ovarian cancer.
Cannistra SA
Gynecol Oncol; 1993 Nov; 51(2):292-4. PubMed ID: 8276314
[No Abstract] [Full Text] [Related]
38. Radioimmunolocalization of breast cancer using BrE-3 monoclonal antibody.
Kramer EL; DeNardo SJ; Liebes L; Noz ME; Kroger L; Glenn SD; Furmanski P; Ceriani R
Adv Exp Med Biol; 1994; 353():181-92. PubMed ID: 7985537
[No Abstract] [Full Text] [Related]
39. Immunoscintigraphy with 111In-satumomab pendetide in patients with colorectal adenocarcinoma: performance and impact on clinical management.
Corman ML; Galandiuk S; Block GE; Prager ED; Weiner GJ; Kahn D; Abdel-Nabi H; Mitchell EP; Pascucci VL; Maroli AN
Dis Colon Rectum; 1994 Feb; 37(2):129-37. PubMed ID: 8306832
[TBL] [Abstract][Full Text] [Related]
40. Differences in biodistribution of indium-111-and iodine-131-labeled B72.3 monoclonal antibodies in patients with colorectal cancer.
Yokoyama K; Carrasquillo JA; Chang AE; Colcher D; Roselli M; Sugarbaker P; Sindelar W; Reynolds JC; Perentesis P; Gansow OA
J Nucl Med; 1989 Mar; 30(3):320-7. PubMed ID: 2738661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
